A case of Chronic Spontaneous Urticaria (CSU) unresponsive to ligelizumab successfully treated with omalizumab.
Dermatologic therapy(2022)
关键词
chronic urticaria,ligelizumab,omalizumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Dermatologic therapy(2022)